Krescix Ad Shedir Pharma is a veterinary product in tablet form, specifically formulated to offer complete protection against flea and tick infestations in dogs. Each pack contains 30 tablets for an effective and long-lasting treatment cycle.
These tablets are designed to ensure easy use and stress-free administration for animals, while ensuring an effective therapeutic and preventive action.
The product acts quickly on infestations, protecting your dog from annoying external parasites that can compromise his well-being and general health.
Easily integrated into the daily routine, Krescix Ad represents a valid support in the prevention of diseases transmitted by fleas and ticks.
Therapeutic Indications
Krescix Ad Shedir Pharma is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis and C. canis) in dogs, ensuring protection that can last for at least five weeks after a single administration. In addition to fleas, it is also effective against ticks, including the Dermacentor reticulatus, Ixodes ricinus and Rhipicephalus sanguineus genera, eliminating them for up to a month.
Its use is part of a strategy also aimed at controlling flea allergic dermatitis (FAD), a condition frequently caused by allergic reactions to pulmonary infestations. Krescix Ad is also used in the treatment of skin diseases caused by mites, such as demodicosis (caused by Demodex canis) and sarcoptic mange (caused by Sarcoptes scabiei var. canis), conditions that require constant and targeted therapy.
The product works through a mechanism that requires the parasites to start biting to come into contact with the active ingredient, thus being extremely effective in preventing the proliferation and reproduction of the parasites themselves.
Composition
Krescix Ad tablets contain as active ingredient a calibrated quantity of specific substances dedicated to antiparasitic treatment, formulated to guarantee maximum effectiveness and safety for the animal. Among the excipients used are corn starch, purified soy proteins, and natural flavors which make the tablets attractive to dogs.
The mixture of excipients also includes binding and stabilizing agents such as povidone, macrogol 400, macrogol 4000 and macrogol 15 hydroxystearate, as well as glycerol (E422) and medium chain triglycerides, which contribute to maintaining the consistency and optimal preservation of the product. This combination guarantees low toxicity and good tolerability even in sensitive subjects.
Contraindications
It is important not to administer Krescix Ad Shedir Pharma in case of known hypersensitivity to the active ingredient or to any of the excipients contained in the formulation. In case of doubts or particular conditions of the animal, it is recommended to consult the veterinarian before starting treatment.
Furthermore, the use of the product is not recommended in puppies under 8 weeks of age and in dogs weighing less than 2 kg, unless a thorough risk-benefit assessment is carried out by the competent veterinarian.
Safety of the drug for the species
Krescix Ad was developed to ensure maximum safety when used on dogs, but it is essential to remember that the effectiveness of the treatment is based on the fact that the parasites begin their blood meal by ingesting the active ingredient. Therefore, it is not possible to completely eliminate the risk of disease transmission by the parasites themselves in the first hours of attack.
The stable and well-tolerated composition minimizes the possibility of side effects, however veterinary surveillance is important throughout the course of treatment to monitor the animal's response and manage any adverse reactions.
Precautions
When using the product, it is essential to take some safety measures to protect both the animal and the person administering the drug. Firstly, it is recommended to remove one tablet at a time from the blister to avoid accidental access by children or other animals. It is also important to store the unused product in its original packaging
